VEGFA and glioma: In 2012, Lee et al. (49) demonstrated that the reduction of tumor size in glioma xenografts after antiangiogenic drugs is not only caused by a reduction of angiogenic proliferation, but also by the dependency of the tumor cells on autocrine and paracrine VEGF stimulation.